Gilead Sciences, Inc. (GILD)
NASDAQ·Healthcare·Drug Manufacturers - General
$131.17
+0.01%
Mkt Cap $161.66B
Analyst Ratings
Buy
15
Hold
1
Sell
0
Price Target (96 analysts)
$161.81
Range $122.00 – $180.00
Implied Upside
+23.4%
Consensus $161.81 vs current $131.17